USC Schaeffer

The prevailing sentiment that new #Alzheimers drugs don’t really work has been a major disservice to families affected by the disease, USC Schaeffer Scholars Paul Aisen and Joe Grogan argue. schaeffer.usc.edu/research/alzhe…

Much of what's known about preventing #dementia comes from research in wealthy countries like the US. A new global study from USC Schaeffer's Center for Economic and Social Research finds risk factors vary widely around the world. #aaic26 today.usc.edu/dementia-risk-…

Dementia isn’t just a health crisis, it’s also an economic one. USC Schaeffer’s Julie Zissimopoulos discusses her new research with @KTLA estimating that dementia will cost the U.S. a staggering $818 billion this year. ktla.com/video/the-hidd…

Medicare prescriptions for Wegovy jumped in the 6 months after the weight-loss drug was approved for heart risk, new USC Schaeffer research shows. However, fewer than 1% of beneficiaries likely eligible had filled a prescription. schaeffer.usc.edu/research/medic…

USC Schaeffer experts recently shared recommendations on a bipartisan legislative proposal to better integrate clinical trials into routine care and expand the use of real-world evidence in regulatory decision-making. schaeffer.usc.edu/research/comme…

Should Congress look beyond the next 10 years when evaluating health care reform? In a new JAMA Health Forum Viewpoint, @USCSchaeffer Co-Directors Dana Goldman and Erin Trish argue that major health policy decisions deserve a broader lens. Considering long-term impacts—from patient health and medical innovation to the economy—can lead to more informed policymaking. Read more about their perspective on rethinking how health reform is evaluated: schaeffer.usc.edu/research/scori…

Medicare this week will start covering GLP-1s for weight-loss, potentially benefiting millions of beneficiaries. USC Schaeffer research on the cost, coverage and value of anti-obesity medications has helped inform this policy shift. schaeffer.usc.edu/research/schae…

DC health debates often center on budget scores, less so on long-term consequences for health outcomes, markets & biomedical innovation. USC Schaeffer’s Dana Goldman & Erin Trish in @JAMAHealthForum suggest complementing CBO analysis w/outside modeling. jamanetwork.com/journals/jama-…

"[Dementia] is a health crisis. It's also an economic crisis for families and government. It's not something to sit back and ignore." -USC Schaeffer's Julie Zissimopoulos on new research estimating dementia will cost the US $818 billion this year.

Dementia costs are staggering yet largely hidden. Our new research estimates that dementia will cost the U.S. $818B this year, driven by often-overlooked costs to people with dementia and family & friends providing care. Our research in @alzdemjournals: schaeffer.usc.edu/research/demen…

For near-retirees who are able to keep working, delaying retirement by just 1 year can be a healthy choice that also generates broader economic benefits. USC Schaeffer's Dana Goldman discusses his new research⬇️

"Even if you live in a wealthy country, if you lack access to clean drinking water, you are far more likely to lack access to food." -USC Schaeffer's Wandi Bruine de Bruin on her new research linking food insecurity & water insecurity. smartwatermagazine.com/news/smart-wat…

Cell and gene therapies are transforming medicine, but significant questions remain about cost, reimbursement & access. Hear USC Schaeffer's Darius Lakdawalla break down these issues in tomorrow's webinar from @MHExecutive. ✒️Registration: globalmeet.webcasts.com/starthere.jsp?…

A proposed California ballot measure to cap medical executives' pay is unlikely to reduce patient costs, USC Schaeffer's Glenn Melnick tells @KFFHealthNews. kffhealthnews.org/medicaid/seiu-…

Today’s near-retirees are healthier and more capable than ever. For those who are able to, choosing to work 1 more year can improve their well-being & America's fiscal outlook. New @thehill op-ed from USC Schaeffer's Dana Goldman & CMS's Anup Malani. thehill.com/opinion/congre…

Medicare could unlock a trove of valuable clinical trial data through relatively modest changes to reporting requirements, USC Schaeffer Scholars Sidra Haye and Mireille Jacobson write in @JAMAHealthForum. schaeffer.usc.edu/research/impro…

Health care costs are putting pressure on families across the country, from rising insurance premiums to higher prescription and out-of-pocket expenses. Erin Duffy of @USCSchaeffer shares why reviewing medical bills closely can make a real difference for patients facing unexpected charges. Read the full story at the link in bio: uscprice.page/4uQ2gfC

GLP-1s may deliver the greatest health and economic benefits to disadvantaged populations, who historically have faced greater barriers to sustained weight loss through behavioral interventions. New NBER working paper from USC Schaeffer scholars ⬇️schaeffer.usc.edu/research/glp-1…

“We do not lack cures. We lack the infrastructure to pay for and deliver them,” writes William Padula. trib.al/0qzotVW

Medicare’s cap on monthly #insulin costs reduced beneficiaries’ spending on the drug by 21% and increased use among those who previously had especially high costs, finds new USC Schaeffer research in JAMA. schaeffer.usc.edu/research/medic…